Abstract
A modest subset of patients who undergo total knee arthroplasty (TKA) will subsequently develop chronic neuropathic knee pain. Initially, patients are treated conservatively with tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, and peripheral nerve blocks with subsequent radiofrequency ablation. With advancements in neuromodulation, particularly dorsal root ganglion stimulation (DRG-S), promising outcomes with sustained pain relief have been shown. Our aim is to review the current literature on the management of chronic neuropathic post-TKA pain with DRG-S.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
